Skip to content

Prospective observational study on short-term and long-term effects of elective performed bronchial artery embolization using gelatin sponge for recurrent hemoptysis or chronic sustained hemosputum

Prospective observational study on short-term and long-term effects of elective performed bronchial artery embolization using gelatin sponge for recurrent hemoptysis or chronic sustained hemosputum - The effects of elective performed bronchial artery embolization for recurrent hemoptysis or chronic sustained hemosputum

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000031309
Enrollment
80
Registered
2018-02-15
Start date
2017-09-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent hemoptysis or chronic sustained hemosputum

Interventions

None listed

Sponsors

National Center for Global Health and Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We enrolled the patients who referred to our hospital due to hemoptysis or chronic hemosputum and treated with the elective super selective bronchial artery embolization(ssBAE) using gelatin sponge.

Exclusion criteria

Exclusion criteria: 1) respiratory arrest 2) hemodynamic instability (hypotension, shock vital, myocardial ischemia or life-threatening arrhythmia) 3)severe respiratory failure patients: Under the mechanical support ventilation, PaO2/FiO2 was lower than 100. 4)severe renal dysfunction or hemodialysis patients 5)delirious state or uncooperative patients 6)can not be maintain the supine position 7)aortic dissection or aortic aneurysm or anatomical abnormality 8)risk of aspiration

Design outcomes

Primary

MeasureTime frame
Short-term and long-term effects of elective performed bronchial artery embolization Total hemostasis rate was observed.

Secondary

MeasureTime frame
Objective indicators: 1) Examine the safety of treatment and complications.

Countries

Japan

Contacts

Public ContactManabu Suzuki

National Center for Global Health Department of Respiratory Medicine

manabu@nms.ac.jp0332027181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026